Cadent Therapeutics

OverviewSuggest Edit

Cadent Therapeutics is a neuroscience company that develops a pipeline of medicines. It offers novel allosteric modulators of ion channels that aim to restore cognitive and motor functions. The Company also develops therapies to treat spinocerebellar ataxia, essential tremor and schizophrenia. 

TypePrivate
Founded2017
HQCambridge, US
Websitecadenttx.com

Latest Updates

Employees (est.) (Jan 2020)26(+4%)

Cadent Therapeutics Office Locations

Cadent Therapeutics has an office in Cambridge
Cambridge, US (HQ)
60 Hamilton Street
Show all (1)

Cadent Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Cadent Therapeutics total Funding

$40 m

Cadent Therapeutics latest funding size

$40 m

Time since last funding

a year ago

Cadent Therapeutics investors

Cadent Therapeutics's latest funding round in November 2018 was reported to be $40 m. In total, Cadent Therapeutics has raised $40 m
Show all financial metrics

Cadent Therapeutics Online and Social Media Presence

Embed Graph

Cadent Therapeutics Blogs

Cadent Therapeutics Announces FDA acceptance of IND Application for CAD-1883 for Spinocerebellar Ataxia (SCA)

Cadent Therapeutics, a clinical stage biopharmaceutical company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, today announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) applicati…

Cadent Therapeutics Announces Poster Presentation at the 2019 Annual Meeting of the American College of Neuropsychopharmacology (ACNP)

Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, today announced a poster presentation of its lead cognitive disorder asset CAD-9303...

Cadent Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference

Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, today announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the...

Cadent Therapeutics to Present at Upcoming Investor Conferences

Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, today announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the following...

Cadent Therapeutics Appoints Christopher Kenney, M.D. as Chief Medical Officer and Provides Clinical Update

Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, announced the appointments of Christopher Kenney, M.D. as Chief Medical Officer and Dawn Wilson as Vice President of Clinical Operations...

Cadent Therapeutics to Present at the 5th Annual BMO Private Company Showcase

Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, today announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the 5th Annual BMO Private Company Showcase...

Cadent Therapeutics Frequently Asked Questions

  • When was Cadent Therapeutics founded?

    Cadent Therapeutics was founded in 2017.

  • How many employees does Cadent Therapeutics have?

    Cadent Therapeutics has 26 employees.

  • Who are Cadent Therapeutics competitors?

    Competitors of Cadent Therapeutics include Xoc Pharmaceuticals, ProPhase Labs and TrovaGene.

  • Where is Cadent Therapeutics headquarters?

    Cadent Therapeutics headquarters is located at 60 Hamilton Street, Cambridge.

  • Where are Cadent Therapeutics offices?

    Cadent Therapeutics has an office in Cambridge.

  • How many offices does Cadent Therapeutics have?

    Cadent Therapeutics has 1 office.